Reuters logo
BRIEF-Pernix Therapeutics qtrly loss per share $2.94
May 15, 2017 / 8:15 PM / 7 months ago

BRIEF-Pernix Therapeutics qtrly loss per share $2.94

May 15 (Reuters) - Pernix Therapeutics Holdings Inc:

* Pernix Therapeutics reports first quarter 2017 financial results and provides business update

* Q1 revenue fell 8.6 percent to $29.7 million

* Pernix Therapeutics Holdings Inc - qtrly loss per share $2.94

* Pernix Therapeutics -net product revenues - other products increased by $0.1 million, or approximately 1%, during three months ended March 31, 2017

* Pernix Therapeutics Holdings Inc says total principal amount of debt outstanding at March 31, 2017 was approximately $320.8 million

* Pernix Therapeutics -agreed that a failure to repay all borrowings under revolving credit facility on or before July 31, would constitute an event of default Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below